TRHC’s SinfoníaRx named a “Top Company to Work for in Arizona” for Third Year in a Row - Tabula Rasa HealthCare

TRHC’s SinfoníaRx named a “Top Company to Work for in Arizona” for Third Year in a Row

Press Releases | Jun 11, 2018

MOORESTOWN, N.J., June 11, 2018 — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, announced today its subsidiary, SinfoníaRx, has earned a spot on the list of 2018 azcentral.com® Top Companies to Work for in Arizona for the third consecutive year.

This highly selective list is the result of anonymous and comprehensive employee surveys measuring culture, work environment, leadership, and employee pride and satisfaction, combined with rigorous evaluations of workplace practices, policies, perks, and demographics.

“These winners should be very proud of their engaged workforces,” says Denise Gredler, Founder and CEO for BestCompaniesAZ, program consulting partner. “This presents a powerful opportunity to attract and retain the very best talent.”

The 100 “Top Companies” were honored at an awards breakfast reception June 7 at the Scottsdale Fairmont Princess and are featured in a special supplement in the June 10 issue of The Arizona Republic.

“We have amazing people at SinfoníaRx,” says Kevin Boesen, CEO of SinfoníaRx. “Since our inception, our priority has been to foster a fun, exciting, and rewarding workplace culture for the hundreds of nationwide healthcare providers we are honored to employ.”

For more information, please visit sinfoniarx.com or topcompanies.azcentral.com.

About SinfoníaRx
SinfoníaRx, a Tabula Rasa HealthCare Company, is a leading provider of Medication Therapy Management (MTM) services. Through a comprehensive suite of innovative healthcare solutions, SinfoníaRx provides direct support to health plans, health systems, provider organizations, and pharmacies. SinfoníaRx’s staff of nationally renowned clinical pharmacists and interprofessional team work directly with caregivers, patients, and providers to ensure the most effective and safest medication therapy possible. For more information, visit, sinfoniarx.com.

Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 14, 2018, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website http://ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.

Share this:
Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4